Cargando…
Alzheimer’s Disease: Current Perspectives and Advances in Physiological Modeling
Though Alzheimer’s disease (AD) is the most common cause of dementia, complete disease-modifying treatments are yet to be fully attained. Until recently, transgenic mice constituted most in vitro model systems of AD used for preclinical drug screening; however, these models have so far failed to ade...
Autores principales: | Josephine Boder, E., Banerjee, Ipsita A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698996/ https://www.ncbi.nlm.nih.gov/pubmed/34940364 http://dx.doi.org/10.3390/bioengineering8120211 |
Ejemplares similares
-
Current Advances in Mitochondrial Targeted Interventions in Alzheimer’s Disease
por: Sousa, Tiago, et al.
Publicado: (2023) -
Enhancing Kidney Vasculature in Tissue Engineering—Current Trends and Approaches: A Review
por: Lebedenko, Charlotta G., et al.
Publicado: (2021) -
Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives
por: Pardo-Moreno, Teresa, et al.
Publicado: (2022) -
Current advances in transdermal delivery of drugs for Alzheimer's disease
por: Nguyen, Thuy Trang, et al.
Publicado: (2017) -
Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
por: McGrowder, Donovan A., et al.
Publicado: (2021)